Literature DB >> 23979450

Cushing's disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review.

J Lindholm1.   

Abstract

The dexamethasone (DXM) test has been widely used for diagnosing Cushing's disease (CD). The purpose of this paper is to review its diagnostic merit based on calculation of data extracted from earlier publications. Studies presenting individual values for patients with CD and normal subjects were identified through PubMed searches and references in pertinent studies. Calculation of the retrieved data demonstrated huge variation in the relative suppressibility, negative suppression being common. Furthermore, in almost each study retrieved, the pre and post DXM values were closely correlated. Finally, the generally accepted view that DXM causes less suppression in Cushing's disease than in euadrenal controls appears unfounded. A central issue in the definition of so-called "pseudo-Cushing's states" is failure to suppress cortisol secretion with DXM. From analysis of the literature it appears quite possible that this does not reflect a specific endocrine deficit, but a physiological "stress" reaction. The above issues question the diagnostic value of the test, in particular in clinically and biochemically borderline cases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23979450     DOI: 10.1007/s11102-013-0509-x

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  61 in total

1.  DIAGNOSIS OF CUSHING'S SYNDROME; SINGLE DOSE DEXAMETHASONE SUPPRESSION TEST.

Authors:  C A NUGENT; T NICHOLS; F H TYLER
Journal:  Arch Intern Med       Date:  1965-08

2.  The reliability of some adrenal function tests.

Authors:  C L COPE; E G BLACK
Journal:  Br Med J       Date:  1959-11-28

Review 3.  Dynamic testing in Cushing's syndrome.

Authors:  Blerina Kola; Ashley B Grossman
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia.

Authors:  L WILKINS; R A LEWIS; R KLEIN; E ROSEMBERG
Journal:  Bull Johns Hopkins Hosp       Date:  1950-04

5.  Endocrine changes in psychiatric diseases.

Authors:  P H Gruen
Journal:  Med Clin North Am       Date:  1978-03       Impact factor: 5.456

6.  Cushing's syndrome: a prospective study of diagnostic methods.

Authors:  R L Eddy; A L Jones; P F Gilliland; J D Ibarra; J Q Thompson; J F MacMurry
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

7.  An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.

Authors:  S B Blunt; L M Sandler; J M Burrin; G F Joplin
Journal:  Q J Med       Date:  1990-11

8.  The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.

Authors:  James W Findling; Hershel Raff; David C Aron
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

9.  CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.

Authors:  A B Grossman; T A Howlett; L Perry; D H Coy; M O Savage; P Lavender; L H Rees; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1988-08       Impact factor: 3.478

10.  Endocrine function in patients with Cushing's disease before and after treatment.

Authors:  J Lindholm
Journal:  Clin Endocrinol (Oxf)       Date:  1992-02       Impact factor: 3.478

View more
  4 in total

1.  The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome.

Authors:  O Aksu; B Aydın; D K Doguç; I Ilhan; O Ozturk; A Altuntas; H Demirkan; B K Koroglu; M N Tamer
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

2.  Effect of single-dose dexamethasone on acute phase response following zoledronic acid: a randomized controlled trial.

Authors:  E O Billington; A Horne; G D Gamble; K Maslowski; M House; I R Reid
Journal:  Osteoporos Int       Date:  2017-02-23       Impact factor: 4.507

3.  Dexamethasone altered steroidogenesis and changed redox status of granulosa cells.

Authors:  Xiao-Hua Yuan; Bai-Qing Yang; Ying Hu; Yang-Yang Fan; Li-Xia Zhang; Jia-Chen Zhou; Ya-Qin Wang; Cai-Ling Lu; Xu Ma
Journal:  Endocrine       Date:  2014-04-11       Impact factor: 3.633

4.  Glycogen storage disease presenting as Cushing syndrome.

Authors:  Margaret A Stefater; Joseph I Wolfsdorf; Nina S Ma; Joseph A Majzoub
Journal:  JIMD Rep       Date:  2019-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.